TGF-beta signaling in cancer

Abstract

Transforming Growth Factor beta (TGF-beta) is a cytokine regulating a wide range of cellular processes such as proliferation, differentiation, and migration. At the early stages of cancer development TGF-beta functions as a tumor suppressor, mainly due to its inhibitory effect on cellular growth, but during cancer progression, mutations in TGF-beta signal components switches TGF-beta into a promoter of cancer cell proliferation, survival and metastasis.

The aim of this thesis was to study the role of TGF-beta signaling in the progression of two different cancer types - diffuse-type gastric carcinoma and neuroblastoma. Furthermore, we wanted to investigate the function in neuroblastoma of the nuclear receptor TLX, a protein involved in neuronal stem cell maintenance, and if TLX interacts with TGF-beta signaling.

We found that disruption of TGF-beta signaling in diffuse-type gastric carcinoma cells led to accelerated tumor growth in vivo through the induction of angiogenesis, possibly due to the repression of anti-angiogenic proteins including TIMP2. In addition, TGF-beta repressed expression of the cancer stem cell marker ABCG2 and diminished a subpopulation of cancer-initiating cells within the main cancer cell population, leading to reduced tumor formation.

TLX expression in neuroblastoma cells inhibited VHL-dependent degradation of HIF2-alpha, which then could bind and activate the VEGF promoter. Silencing of TLX induced VHL protein levels, reduced hypoxia-dependent induction of HIF2-alpha and inhibited cell proliferation. Furthermore, we found that TLX knockdown induced TGF-beta response in neuroblastoma cells as seen by increased TGF-beta dependent expression of its target genes p21 and Smad7. TLX physically interacts with Smad3 and knockdown of TLX led to increased TGF-beta dependent nuclear translocation of Smad2/3.

In conclusion, the results from this thesis suggest that TGF-beta signaling has an important tumor suppressive role in diffuse-type gastric carcinoma, due to both inhibition of tumor angiogenesis and repression of a cancer-initiating subpopulation of cancer cells. Furthermore, TLX was shown to be important for neuroblastoma cell proliferation, with a possible role in hypoxia-induced angiogenesis as well as in the regulation of TGF-beta signaling in neuroblastoma.